17 March 2017
Redshift receives $11m in series C round
Waters Corporation has co-led a round that took bioanalytical technology producer Redshift Bioanalytics' total funding to $35m since 2005.
Author: Robert Lavine, News Editor
Redshift Bioanalytics, a US-based developer of bioanalytical tools for the life sciences industry, has completed an $11m series C round co-led by laboratory equipment producer Waters Corporation.